NORTHUMBERLAND, TYNE AND WEAR NHS FOUNDATION TRUST
Transactions
NORTHUMBERLAND, TYNE AND WEAR NHS FOUNDATION TRUST has received £75,386,407 from 1 department.
Income
Contracts
No contracts
By department
Top departments
By expense area
Top expense areas
-
1
Default Group
Department of Health and Social Care · 2021–2022
£62 Million
~£31M/yr
-
2
Chief Scientific Advisor
Department of Health and Social Care · 2021–2023
£9.1 Million
~£3M/yr
-
3
Holding CT Core
Department of Health and Social Care · 2020
£2.09 Million
-
4
CHIEF SCIENTIFIC ADVISOR
Department of Health and Social Care · 2020
£2.04 Million
-
5
NHSX
Department of Health and Social Care · 2021–2022
£140 Thousand
~£70.1K/yr
By expense type
Top expense types
-
1
Additions NCB PDC
Department of Health and Social Care · 2021–2022
£66.4 Million
~£33.2M/yr
-
2
Research & development
Department of Health and Social Care · 2020–2023
£11.1 Million
~£2.8M/yr
-
3
Additions PDC Capital Support NHS FT Permanent
Department of Health and Social Care · 2020
£1.35 Million
-
4
Additions-PDC permanent
Department of Health and Social Care · 2020
£740 Thousand
-
5
Revenue Grants to Other Bodies
Department of Health and Social Care · 2020–2022
£192 Thousand
~£64.1K/yr
-
6
Interest Receivable NCB Loan
Department of Health and Social Care · 2022
£-827 Thousand
-
7
Dividends receivable on PDC
Department of Health and Social Care · 2022
£-937 Thousand
-
8
Curr Part of Lns Repay Tfr from Invest (ST) NCB Loan
Department of Health and Social Care · 2022
£-2.61 Million
Recent payments
| Date | Buyer | Amount | Expense area | Expense type | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-27 | £30,706 | Chief Scientific Advisor | Research & development | ||||||||
| Research Capability Funding - Standard | |||||||||||
| 2023-01-13 | £223,800 | Chief Scientific Advisor | Research & development | ||||||||
| Applied Research Collaborations (ARCs) | |||||||||||
| 2022-12-23 | £72,328 | Chief Scientific Advisor | Research & development | ||||||||
| HTA Commissioned | |||||||||||
| 2022-12-23 | £30,706 | Chief Scientific Advisor | Research & development | ||||||||
| Research Capability Funding - Standard | |||||||||||
| 2022-12-19 | -£262,095 | Default Group | Interest Receivable NCB Loan | ||||||||
| RX4.FTFF.07.2012 | |||||||||||
| 2022-12-19 | -£852,000 | Default Group | Curr Part of Lns Repay Tfr from Invest (ST) NCB Loan | ||||||||
| RX4.FTFF.07.2012 | |||||||||||
| 2022-12-13 | £223,800 | Chief Scientific Advisor | Research & development | ||||||||
| Applied Research Collaborations (ARCs) | |||||||||||
| 2022-11-25 | £30,706 | Chief Scientific Advisor | Research & development | ||||||||
| Research Capability Funding - Standard | |||||||||||
| 2022-11-11 | £227,159 | Chief Scientific Advisor | Research & development | ||||||||
| Applied Research Collaborations (ARCs) | |||||||||||
| 2022-11-02 | £30,706 | Chief Scientific Advisor | Research & development | ||||||||
| Research Capability Funding - Standard | |||||||||||
| 2022-10-17 | £220,439 | Chief Scientific Advisor | Research & development | ||||||||
| Applied Research Collaborations (ARCs) | |||||||||||
| 2022-10-17 | £45,000 | Chief Scientific Advisor | Research & development | ||||||||
| Research for patients benefit programme (RFPB) | |||||||||||
| 2022-10-17 | £72,328 | Chief Scientific Advisor | Research & development | ||||||||
| HTA Commissioned | |||||||||||
| 2022-10-17 | £30,706 | Chief Scientific Advisor | Research & development | ||||||||
| Research Capability Funding - Standard | |||||||||||
| 2022-09-19 | -£60,000 | Default Group | Curr Part of Lns Repay Tfr from Invest (ST) NCB Loan | ||||||||
| ITFF/NCCIL/RX4/2015-02-10/A | |||||||||||
| 2022-09-15 | -£657,000 | Default Group | Dividends receivable on PDC | ||||||||
| RX4 PDCDIVSEP22 RX4 | |||||||||||
| 2022-09-13 | £207,106 | Chief Scientific Advisor | Research & development | ||||||||
| Applied Research Collaborations (ARCs) | |||||||||||
| 2022-08-26 | £30,706 | Chief Scientific Advisor | Research & development | ||||||||
| Research Capability Funding - Standard | |||||||||||
| 2022-08-18 | -£63,317 | Default Group | Interest Receivable NCB Loan | ||||||||
| ITFF/NCCIL/RX4/2015-07-07/A | |||||||||||
| 2022-08-18 | -£80,378 | Default Group | Interest Receivable NCB Loan | ||||||||
| ITFF/CILFF/RX4/2014-01-21/A | |||||||||||
Showing 1 to 20 of 126 transactions
Frequently asked questions
What is the latest payment data available for NORTHUMBERLAND, TYNE AND WEAR NHS FOUNDATION TRUST?
The most recent payment data we have available for NORTHUMBERLAND, TYNE AND WEAR NHS FOUNDATION TRUST is from January 2023. Government departments and public bodies typically publish their spending data on a monthly or quarterly basis.
How has NORTHUMBERLAND, TYNE AND WEAR NHS FOUNDATION TRUST's government income changed over time?
NORTHUMBERLAND, TYNE AND WEAR NHS FOUNDATION TRUST's government income has decreased over time. In 2023, they received £254,506, compared to £25,155,677 in 2022 - a decrease of 99.0%.
How much has NORTHUMBERLAND, TYNE AND WEAR NHS FOUNDATION TRUST received from the UK government?
NORTHUMBERLAND, TYNE AND WEAR NHS FOUNDATION TRUST has received a total of £75,386,407 from UK government organisations according to our records. This income comes from 1 government buyer.
Which government departments buy from NORTHUMBERLAND, TYNE AND WEAR NHS FOUNDATION TRUST?
The primary government buyer from NORTHUMBERLAND, TYNE AND WEAR NHS FOUNDATION TRUST is Department of Health and Social Care, which has spent £75,386,408.